Neuphoria Therapeutics (NEUP) Stock Chart & Stock Price History $7.02 0.00 (0.00%) As of 07/2/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock Neuphoria Therapeutics Stock Price Performance The Neuphoria Therapeutics (NEUP) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 2.48%, reflecting recent market activity. As of the latest close, Neuphoria Therapeutics traded at $7.02 with a market cap of $13.20 million and volume of 43,410 shares. Receive NEUP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neuphoria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.29%1 Month Performance+2.48%3 Month Performance+24.03% NEUP Stock Chart for Thursday, July, 3, 2025 NEUP Chart by TradingView Neuphoria Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$7.02$7.02$7.33$7.0043,410 shs$13.20 million07/01/2025$7.10$7.02-1.13%$7.30$6.8545,874 shs$13.20 million06/30/2025$7.00$7.10+1.43%$7.37$6.8045,733 shs$13.35 million06/27/2025$6.80$7.00+2.94%$7.41$6.8049,447 shs$13.16 million06/26/2025$7.00$6.80-2.86%$7.67$6.8054,127 shs$12.78 million06/25/2025$6.20$7.00+12.90%$7.00$6.2940,740 shs$13.16 million06/24/2025$6.05$6.20+2.48%$6.23$5.9910,168 shs$11.66 million06/23/2025$6.80$6.05-11.03%$6.79$6.0057,764 shs$11.37 million06/20/2025$6.62$6.80+2.72%$6.80$6.705,769 shs$12.78 million06/19/2025$6.62$6.62$6.91$6.625,087 shs$12.45 million Get the Latest News and Ratings for NEUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neuphoria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$6.76$6.62-2.07%$6.91$6.625,087 shs$12.45 million06/17/2025$6.70$6.76+0.90%$6.79$6.658,695 shs$12.71 million06/16/2025$6.82$6.70-1.76%$6.95$6.6014,590 shs$12.60 million06/13/2025$7.14$6.82-4.48%$7.19$6.6013,298 shs$12.82 million06/12/2025$7.15$7.14-0.14%$7.25$7.0212,970 shs$13.42 million06/11/2025$7.18$7.15-0.42%$7.28$7.0623,019 shs$13.44 million06/10/2025$6.82$7.18+5.28%$7.20$6.829,676 shs$13.50 million06/09/2025$6.87$6.82-0.73%$7.11$6.6929,593 shs$12.82 million06/06/2025$7.15$6.87-3.92%$7.35$6.6730,647 shs$12.92 million06/05/2025$7.15$7.15$7.34$7.0416,151 shs$13.44 million06/04/2025$6.85$7.15+4.38%$7.35$6.8532,878 shs$13.44 million06/03/2025$7.01$6.85-2.28%$7.04$6.7619,583 shs$12.88 million06/02/2025$6.55$7.01+7.02%$7.24$6.7743,954 shs$13.18 million Related Companies IPA Stock Chart TELO Stock Chart VTVT Stock Chart RNXT Stock Chart IPSC Stock Chart BLUE Stock Chart PRLD Stock Chart STTK Stock Chart KLRS Stock Chart AADI Stock Chart Receive NEUP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neuphoria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NEUP) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | SponsoredMake 22x more from this summer’s Bitcoin boomBitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEUP Stock Alerts